Brighton Biotech Competitors and Similar CompaniesClear all

Brighton Biotech's competitors and similar companies include Avenge Bio, Amberstone Biosciences, Pfizer and Cyclacel Pharmaceuticals.

	Brighton Biotech Brighton Biotech is a company that specializes in acquiring and developing pharmaceutical products intended for the treatment and prevention of serious medical needs.	Avenge Bio Avenge Bio is a company developing cell-generated immunotherapies to treat solid tumors.	Amberstone Biosciences Amberstone Biosciences is a biotechnology company developing tumor-activated immunotherapeutics.	Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.	Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals develops oral therapies to treat cancers and other serious diseases.
Founding Date	Founding Date 2010	Founding Date 2019	Founding Date 2018	Founding Date 1849	Founding Date 1992
Type	Type Private	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech genetics oncology platform	Tags Healthcare biotech clinical research drug development medtech therapy	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech clinical research drug development pharma
Locations	Locations New York, US HQ	Locations Natick, US HQ	Locations Irvine, US HQ	Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more	Locations Berkeley Heights, US HQ Dundee City, GB
Employees	Employees N/A	Employees N/A	Employees 166% decrease	Employees 81,0008% decrease	Employees 1214% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 163.9 b	Valuation ($) 1.5 m
Financial
Net income	Net income N/A	Net income N/A	Net income N/A	Net income $7.8b (FY, 2025)	Net income ($14.1m) (FY, 2025)
Funding
Latest funding round	Latest funding round $ 1.6m (over 11 years ago)	Latest funding round $ 45m (over 4 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 1.6m	Total funding raised $ 45m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 152.2m